🇺🇸 FDA
Patent

US 10293000

Methods and compositions for the treatment of lysosomal storage diseases

granted A61KA61K35/28A61K38/46

Quick answer

US patent 10293000 (Methods and compositions for the treatment of lysosomal storage diseases) held by Sangamo Therapeutics, Inc. expires Mon May 16 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Sangamo Therapeutics, Inc.
Grant date
Tue May 21 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 16 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
7
CPC classes
A61K, A61K35/28, A61K38/46, A61K38/465, A61K48/00